11 companies

AddLife

Market Cap: SEK 19.6b

Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.

ALIF B

SEK 160.80

7D

5.6%

1Y

-19.0%

Bonesupport Holding

Market Cap: SEK 15.0b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

BONEX

SEK 227.40

7D

0.5%

1Y

-10.2%

Swedencare

Market Cap: SEK 4.4b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

SECARE

SEK 27.70

7D

0.4%

1Y

-34.7%

Devyser Diagnostics

Market Cap: SEK 1.5b

Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.

DVYSR

SEK 89.70

7D

-2.7%

1Y

-21.3%

Cinclus Pharma Holding

Market Cap: SEK 565.9m

A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.

CINPHA

SEK 12.16

7D

-0.5%

1Y

-30.6%

Mendus

Market Cap: SEK 312.9m

A biopharmaceutical company, develops immunotherapies for the treatment of myeloid blood cancers.

IMMU

SEK 5.10

7D

0.6%

1Y

-20.6%

Promimic

Market Cap: SEK 198.4m

Engages in the manufacturing, marketing, and sale of biomaterials for improved osseointegration in the orthopedic and dental implants markets in Sweden.

PRO

SEK 10.50

7D

-7.9%

1Y

-48.5%

Diamyd Medical

Market Cap: SEK 178.2m

Develops precision medicine therapies for the treatment of autoimmune diabetes.

DMYD B

SEK 1.15

7D

2.5%

1Y

-88.4%

IDL Diagnostics

Market Cap: SEK 104.8m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

IDLDX

SEK 0.46

7D

-7.0%

1Y

-15.1%

Alzinova

Market Cap: SEK 75.3m

A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.

ALZ

SEK 0.49

7D

9.0%

1Y

-72.7%

PharmaLundensis

Market Cap: SEK 15.3m

PharmaLundensis AB operates as a pharmaceutical company.

PHAL

SEK 0.36

7D

0%

1Y

-44.6%